Article
Use of whole genome sequencing in surveillance of drug resistant tuberculosis.
Expert review of anti-infective therapy - 1 May 2018
McNerney Ruth, Zignol Matteo, Clark Taane G
Abstract excerpt
INTRODUCTION: The threat of resistance to anti-tuberculosis drugs is of global concern. Current efforts to monitor resistance rely on phenotypic testing where cultured bacteria are exposed to critical concentrations of the drugs. Capacity for such testing is low in TB endemic countries. Drug resistance is caused by mutations in the Mycobacterium tuberculosis genome and whole genome sequencing to detect these...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
